Table 5.

Ratings of resources considered helpful efforts to reduce concurrent use of opioids and benzodiazepines among patients with high risk conditions

	Primary Care, %					Mental Health, %
	n	Not at all/Slightly	Moderately	Extremely/Quite a bit	N/A	n	Not at all/Slightly	Moderately	Extremely/Quite a bit	N/A
Tapering guidelines	51	11.8	19.6	66.7	2.0	31	25.8	9.7	58.1	6.5
Consultation with experts*	51	9.8	13.7	76.5	0.0	31	22.6	22.6	48.4	6.5
Continuing education/skills training	51	13.7	29.4	56.9	0.0	30	26.7	20.0	50.0	3.3
More time with patients	51	9.8	17.7	72.6	0.0	31	6.5	9.7	80.7	3.2
Identification of patients who are prescribed these medications	51	10.0	18.0	72.0	0.0	30	10.0	13.3	73.3	3.3
Firm policies that support decisions to discontinue these medications	51	9.8	9.8	80.4	0.0	31	29.0	9.7	61.3	0.0
Improved communication with prescribers	50	12.0	20.0	68.0	0.0	31	3.2	25.8	71.0	0.0
Accessible clinical practice guidelines	51	17.7	23.5	56.9	2.0	31	25.8	9.7	61.3	3.2
Approved strategies for patients who refuse to consider discontinuation of opioid/bzd medications	50	4.0	10.0	86.0	0.0	31	3.2	9.7	87.1	0.0
Access to alternative medication interventions*	51	11.8	7.8	80.4	0.0	31	9.7	19.4	61.3	9.7
Access to alternative behavioral interventions	49	4.0	10.0	86.0	0.0	31	3.2	16.1	74.2	6.5

N/A – (resource is available)

^*p< 0.05